Is MEDOF or QYLD a better dividend investment in 2026?

MEDOF currently yields 4.00% with a 5% 5-year dividend growth rate. QYLD yields 11.92% with -2.1% growth. The better choice depends on your goal: QYLD offers higher current income.

What is the dividend yield difference between MEDOF and QYLD?

MEDOF has a forward dividend yield of 4.00% ($2.00/share annually). QYLD yields 11.92% ($2.04/share annually). The yield gap is 7.92 percentage points.

Home › Compare › MEDOF vs QYLD

MEDOF vs QYLD: Dividend Comparison 2026

MEDOF yields 4.00% · QYLD yields 11.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MEDOF wins by $550.00 in total portfolio value

INVESTMENT

TIME HORIZON10 years

MEDOF

● Live price

4.00%

Share price

$50.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.9K

Annual income

$517.11

Full MEDOF calculator →

QYLD

Global X Nasdaq 100 Covered Call ETF

● Live price

11.92%

Share price

$17.15

Annual div

$2.04

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$25.4K

Annual income

$5,659.31

Full QYLD calculator →

Portfolio growth — MEDOF vs QYLD

📍 MEDOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MEDOF	QYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MEDOF + QYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MEDOF pays

QYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDOF

Annual income on $10K today (after 15% tax)

$340.00/yr

After 10yr DRIP, annual income (after tax)

$439.54/yr

QYLD

Annual income on $10K today (after 15% tax)

$1,013.51/yr

After 10yr DRIP, annual income (after tax)

$4,810.41/yr

At 15% tax rate, QYLD beats the other by $4,370.87/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDOF + QYLD for your $10,000?

MEDOF: 50%QYLD: 50%

100% QYLD50/50100% MEDOF

Portfolio after 10yr

$25.7K

Annual income

$3,088.22/yr

Blended yield

12.03%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MEDOF right now

MEDOF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

4.2

Piotroski

5/9

QYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDOF buys

QYLD buys

No recent congressional trades found for MEDOF or QYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMEDOFQYLD

Forward yield	4.00%	11.92% ✓
Annual dividend / share	$2.00	$2.04 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$25.9K ✓	$25.4K
Annual income after 10y	$517.11	$5,659.31 ✓
Total dividends collected	$4.6K	$27.1K ✓
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: MEDOF vs QYLD ($10,000, DRIP)

Year	MEDOF Portfolio	MEDOF Income/yr	QYLD Portfolio	QYLD Income/yr	Gap
1← crossover	$11,100	$400.00	$10,352	$1,192.36	+$748.00 → MEDOF
2	$12,292	$414.95	$10,830	$1,347.57	+$1.5K → MEDOF
3	$13,582	$429.45	$11,460	$1,539.07	+$2.1K → MEDOF
4	$14,976	$443.47	$12,275	$1,777.84	+$2.7K → MEDOF
5	$16,481	$457.01	$13,323	$2,078.95	+$3.2K → MEDOF
6	$18,105	$470.04	$14,667	$2,463.34	+$3.4K → MEDOF
7	$19,855	$482.57	$16,396	$2,960.57	+$3.5K → MEDOF
8	$21,739	$494.59	$18,631	$3,612.97	+$3.1K → MEDOF
9	$23,767	$506.10	$21,548	$4,482.15	+$2.2K → MEDOF
10	$25,948	$517.11	$25,398	$5,659.31	+$550.00 → MEDOF

MEDOF vs QYLD: Complete Analysis 2026

MEDOF — Stock

Medios AG, together with its subsidiaries, engages in the wholesale of specialty pharmaceutical drugs in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies; and patient-specific therapies for dispensing individually dosed tablets. The company was founded in 2016 and is based in Berlin, Germany.

Full MEDOF Calculator →

QYLD — ETF

The Global X Nasdaq 100 Covered Call ETF (QYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Nasdaq-100 BuyWrite V2 Index.

Full QYLD Calculator →

📬

Get this MEDOF vs QYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDOF vs SCHD MEDOF vs JEPI MEDOF vs O MEDOF vs KO MEDOF vs MAIN MEDOF vs XYLD MEDOF vs JEPQ MEDOF vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.